Orthofix Medical Stock Analysis
OFIX Stock | USD 16.63 0.27 1.60% |
Orthofix Medical is undervalued with Real Value of 20.78 and Target Price of 24.4. The main objective of Orthofix Medical stock analysis is to determine its intrinsic value, which is an estimate of what Orthofix Medical is worth, separate from its market price. There are two main types of Orthofix Medical's stock analysis: fundamental analysis and technical analysis.
The Orthofix Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Orthofix Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Orthofix Stock trading window is adjusted to America/New York timezone.
Orthofix |
Orthofix Stock Analysis Notes
About 87.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.29. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthofix Medical has Price/Earnings To Growth (PEG) ratio of 0.33. The entity recorded a loss per share of 3.3. The firm had not issued any dividends in recent years. Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Orthofix Intl operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1087 people. To find out more about Orthofix Medical contact Massimo Calafiore at 214 937 2000 or learn more at https://orthofix.com.Orthofix Medical Quarterly Total Revenue |
|
Orthofix Medical Investment Alerts
Orthofix Medical generated a negative expected return over the last 90 days | |
The company reported the previous year's revenue of 799.49 M. Net Loss for the year was (126 M) with profit before overhead, payroll, taxes, and interest of 558.07 M. | |
Orthofix Medical has a poor financial position based on the latest SEC disclosures | |
Over 87.0% of the company shares are owned by institutional investors | |
Latest headline from seekingalpha.com: Orthofix gets FDA clearance and CE Mark for its limb preservation solution |
Orthofix Medical Upcoming and Recent Events
Earnings reports are used by Orthofix Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of March 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Orthofix Largest EPS Surprises
Earnings surprises can significantly impact Orthofix Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
1996-07-25 | 1996-06-30 | 0.06 | 0.05 | -0.01 | 16 | ||
2022-08-05 | 2022-06-30 | 0.1 | 0.08 | -0.02 | 20 | ||
1997-10-27 | 1997-09-30 | 0.11 | 0.13 | 0.02 | 18 |
Orthofix Medical Environmental, Social, and Governance (ESG) Scores
Orthofix Medical's ESG score is a quantitative measure that evaluates Orthofix Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Orthofix Medical's operations that may have significant financial implications and affect Orthofix Medical's stock price as well as guide investors towards more socially responsible investments.
Orthofix Medical Thematic Classifications
In addition to having Orthofix Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | ObamacareCompanies that count on Obamacare to take off |
Orthofix Stock Institutional Investors
Shares | Soleus Capital Management, L.p. | 2024-12-31 | 686.4 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 659.5 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 625.1 K | Emerald Mutual Fund Advisers Trust | 2024-12-31 | 503.8 K | Northern Trust Corp | 2024-12-31 | 368.1 K | Awm Investment Company Inc | 2024-12-31 | 360.1 K | Charles Schwab Investment Management Inc | 2024-12-31 | 339.5 K | Jpmorgan Chase & Co | 2024-12-31 | 290.4 K | Goldman Sachs Group Inc | 2024-12-31 | 235.4 K | Rubric Capital Management Lp | 2024-12-31 | 3.7 M | Engine Capital Management Lp | 2024-12-31 | 3.5 M |
Orthofix Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 648.94 M.Orthofix Profitablity
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.21) | (0.20) | |
Return On Capital Employed | (0.12) | (0.11) | |
Return On Assets | (0.14) | (0.13) | |
Return On Equity | (0.25) | (0.23) |
Management Efficiency
Orthofix Medical has return on total asset (ROA) of (0.045) % which means that it has lost $0.045 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2287) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.2 in 2025. Return On Capital Employed is likely to rise to -0.11 in 2025. At this time, Orthofix Medical's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 27.8 M in 2025, whereas Total Assets are likely to drop slightly above 452.8 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 13.19 | 11.25 | |
Tangible Book Value Per Share | 5.49 | 4.60 | |
Enterprise Value Over EBITDA | (41.78) | (39.69) | |
Price Book Value Ratio | 1.32 | 2.38 | |
Enterprise Value Multiple | (41.78) | (39.69) | |
Price Fair Value | 1.32 | 2.38 | |
Enterprise Value | 762.2 M | 447.2 M |
The operational strategies employed by Orthofix Medical management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Technical Drivers
As of the 23rd of March, Orthofix Medical holds the Coefficient Of Variation of (1,454), risk adjusted performance of (0.06), and Variance of 2.33. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orthofix Medical, as well as the relationship between them.Orthofix Medical Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Orthofix Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Orthofix Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Orthofix Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Orthofix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Orthofix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Orthofix Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Orthofix Medical Outstanding Bonds
Orthofix Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Orthofix Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Orthofix bonds can be classified according to their maturity, which is the date when Orthofix Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Orthofix Medical Predictive Daily Indicators
Orthofix Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Orthofix Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Orthofix Medical Corporate Filings
F4 | 20th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 13th of March 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 12th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
27th of February 2025 Other Reports | ViewVerify | |
8K | 25th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
14th of February 2025 Other Reports | ViewVerify | |
F4 | 5th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Orthofix Medical Forecast Models
Orthofix Medical's time-series forecasting models are one of many Orthofix Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orthofix Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Orthofix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Orthofix Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orthofix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orthofix Medical. By using and applying Orthofix Stock analysis, traders can create a robust methodology for identifying Orthofix entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.15) | (0.15) | |
Operating Profit Margin | (0.11) | (0.10) | |
Net Loss | (0.15) | (0.15) | |
Gross Profit Margin | 0.68 | 0.59 |
Current Orthofix Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Orthofix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Orthofix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
24.4 | Buy | 5 | Odds |
Most Orthofix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Orthofix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Orthofix Medical, talking to its executives and customers, or listening to Orthofix conference calls.
Orthofix Stock Analysis Indicators
Orthofix Medical stock analysis indicators help investors evaluate how Orthofix Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Orthofix Medical shares will generate the highest return on investment. By understating and applying Orthofix Medical stock analysis, traders can identify Orthofix Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow | 37.8 M | |
Long Term Debt | 157 M | |
Common Stock Shares Outstanding | 38.1 M | |
Total Stockholder Equity | 503.1 M | |
Tax Provision | 2.1 M | |
Property Plant And Equipment Net | 139.8 M | |
Cash And Short Term Investments | 83.2 M | |
Cash | 83.2 M | |
Accounts Payable | 48.8 M | |
Net Debt | 96.4 M | |
50 Day M A | 17.7208 | |
Total Current Liabilities | 168.6 M | |
Other Operating Expenses | 884.1 M | |
Non Current Assets Total | 460 M | |
Forward Price Earnings | 20.0401 | |
Non Currrent Assets Other | 26.5 M | |
Stock Based Compensation | 32.5 M |
Additional Tools for Orthofix Stock Analysis
When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.